Results 51 to 60 of about 685,742 (313)

Conditioning Regimens for Hematopoietic Cell Transplantation in Primary Immunodeficiency [PDF]

open access: yes, 2019
Purpose of Review Hematopoietic cell transplantation (HCT) is an established curative treatment for children with primary immunodeficiencies. This article reviews the latest developments in conditioning regimens for primary immunodeficiency (PID).
Hoenig, M   +7 more
core   +3 more sources

Autologous hematopoietic stem cell transplantation in systemic sclerosis: nursing actions

open access: yesRevista Eletrônica de Enfermagem, 2014
The objective of this cross-sectional study was to identify the complications and the implemented nursing actions in systemic sclerosis patients undergoing autologous hematopoietic stem cell transplantation, during the conditioning regimen.
Carolina Scoqui Guimarães   +3 more
doaj   +1 more source

Successful allogeneic bone marrow transplantation using immunosuppressive conditioning regimen for a patient with red blood cell transfusion-dependent pyruvate kinase deficiency anemia

open access: yesHematology Reports, 2020
Pyruvate kinase deficiency (PKD) is the rare glycolytic enzyme defect causing hemolytic anemia. Treatments are mainly red cell transfusion and/or splenectomy, leading to iron overload.
Maiko Shimomura   +7 more
doaj   +1 more source

Post-Transplant Hepatic Steatosis: A Condition Not to Overlook

open access: yesJournal of Clinical Medicine, 2023
Recurrent or de novo steatotic liver disease (SLD) following liver transplantation (LT) is a rising concern among liver transplant recipients [...]
Iyiad Alabdul Razzak   +3 more
openaire   +2 more sources

Bone Mineral Density After Contemporary Treatment for Acute Lymphoblastic Leukaemia: A Matched Cross‐Sectional Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Reduced bone mineral density (BMD) has been reported in survivors of childhood and young adult acute lymphoblastic leukaemia (ALL); however, data from cohorts treated with contemporary protocols and including matched controls remain limited.
Karen Schow Jensen   +10 more
wiley   +1 more source

Comorbid Conditions in Kidney Transplantation [PDF]

open access: yesJournal of the American Society of Nephrology, 2005
Although the impact of comorbidity on outcomes in ESRD has been evaluated extensively, its contribution after kidney transplantation has not been well studied. It is believed that comorbidity assessment is critical to the informed interpretation of kidney transplant outcomes. In this study, the Charlson Comorbidity Index was used to assess the comorbid
Christine, Wu   +9 more
openaire   +2 more sources

An overview of conditioning regimens for haploidentical stem cell transplantation with post-transplantation cyclophosphamide

open access: yes, 2015
Haploidentical related donors are an attractive alternative source of stem cells for allogeneic stem cell transplantation due to widespread availability and ease of stem cell procurement.
Lombardi, Lindsey   +2 more
core   +1 more source

“We Cannot Talk as a Family”: Complexities of Survivorship Communication Among Hispanic/Latino Young Adult Survivors of Childhood Cancer, Parents, and Clinicians

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Young adult childhood cancer survivors (YA‐CCS) have an increased risk of treatment‐related health complications throughout their lives. Lifelong survivorship care is recommended, yet many YA‐CCS experience disruptions in care during pediatric‐to‐adult transitions and do not receive recommended survivorship care.
Kevin Shanchen Pu   +8 more
wiley   +1 more source

Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single Center

open access: yesBalkan Medical Journal, 2023
Background: Allogeneic hematopoietic stem cell transplantation is a well-established approach for patients diagnosed with primary myelofibrosis and remains the only potentially curative treatment.
Guldane Cengiz Seval   +10 more
doaj   +1 more source

Transplant acceptance-inducing cells as an immune-conditioning therapy in renal transplantation

open access: yesTransplant International, 2008
The transplant acceptance-inducing cell (TAIC) is a type of immunoregulatory macrophage with the capacity to specifically dampen allogeneic rejection responses to a degree allowing safe minimization of conventional immunosuppressive therapy. In the first part of this report, the production and phenotype of the human TAIC is described.
James A, Hutchinson   +8 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy